Expert Review of Clinical Pharmacology

Taylor & Francis

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Expert Review of Clinical Pharmacology is a journal published by Taylor & Francis in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Taylor & Francis
ISSN
1751-2433 · 1751-2441
Country
United Kingdom
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2011-01-01
  • PUBMED · 2008-05-01
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1932

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

82

i10-index

1014

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
99%
ORCID iDs in current deposits
48%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101278296
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
Show all subjects (50)
  • Pharmacological Effects and Toxicity Studies
  • Pharmacological Effects and Toxicity Studies
  • Antibiotics Pharmacokinetics and Efficacy
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Antibiotics Pharmacokinetics and Efficacy
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health
  • Pharmaceutical Economics and Policy
  • HIV/AIDS drug development and treatment
  • Pharmaceutical Economics and Policy
  • Rheumatoid Arthritis Research and Therapies
  • HIV/AIDS drug development and treatment
  • Biosimilars and Bioanalytical Methods
  • Rheumatoid Arthritis Research and Therapies
  • Biosimilars and Bioanalytical Methods
  • Epilepsy research and treatment
  • Epilepsy research and treatment
  • Psoriasis: Treatment and Pathogenesis
  • Psoriasis: Treatment and Pathogenesis
  • Schizophrenia research and treatment
  • Schizophrenia research and treatment
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacovigilance and Adverse Drug Reactions
  • Liver Disease Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Pharmacology and Obesity Treatment
  • Computational Drug Discovery Methods
  • Cancer Immunotherapy and Biomarkers
  • Pharmacology and Obesity Treatment
  • Computational Drug Discovery Methods
  • Cancer Immunotherapy and Biomarkers
  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Treatment of Major Depression
  • Treatment of Major Depression
  • Atrial Fibrillation Management and Outcomes
  • Dermatology and Skin Diseases
  • Dermatology and Skin Diseases
  • Pancreatic function and diabetes

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: